233 related articles for article (PubMed ID: 34735553)
1. The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function.
Sultana MA; Cluning C; Kwong WS; Polain N; Pavlos NJ; Ratajczak T; Walsh JP; Xu J; Rea SL
PLoS One; 2021; 16(11):e0259556. PubMed ID: 34735553
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R
J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332
[TBL] [Abstract][Full Text] [Related]
4. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
[TBL] [Abstract][Full Text] [Related]
5. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
[TBL] [Abstract][Full Text] [Related]
6. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.
Goode A; Long JE; Shaw B; Ralston SH; Visconti MR; Gianfrancesco F; Esposito T; Gennari L; Merlotti D; Rendina D; Rea SL; Sultana M; Searle MS; Layfield R
Biochim Biophys Acta; 2014 Jul; 1842(7):992-1000. PubMed ID: 24642144
[TBL] [Abstract][Full Text] [Related]
7. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex.
Feng Y; Longmore GD
Mol Cell Biol; 2005 May; 25(10):4010-22. PubMed ID: 15870274
[TBL] [Abstract][Full Text] [Related]
8. Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling.
Long J; Garner TP; Pandya MJ; Craven CJ; Chen P; Shaw B; Williamson MP; Layfield R; Searle MS
J Mol Biol; 2010 Feb; 396(1):178-94. PubMed ID: 19931284
[TBL] [Abstract][Full Text] [Related]
9. Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-κB in human osteoclasts.
Chamoux E; McManus S; Laberge G; Bisson M; Roux S
Biochim Biophys Acta; 2013 Mar; 1832(3):475-84. PubMed ID: 23266528
[TBL] [Abstract][Full Text] [Related]
10. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
Foster A; Scott D; Layfield R; Rea SL
Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
[TBL] [Abstract][Full Text] [Related]
11. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
[TBL] [Abstract][Full Text] [Related]
12. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
13. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
Wright T; Rea SL; Goode A; Bennett AJ; Ratajczak T; Long JE; Searle MS; Goldring CE; Park BK; Copple IM; Layfield R
Bone; 2013 Feb; 52(2):699-706. PubMed ID: 23117207
[TBL] [Abstract][Full Text] [Related]
14. ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation.
Foster AD; Downing P; Figredo E; Polain N; Stott A; Layfield R; Rea SL
Mol Cell Neurosci; 2020 Oct; 108():103539. PubMed ID: 32835772
[TBL] [Abstract][Full Text] [Related]
15. p62 mutations, ubiquitin recognition and Paget's disease of bone.
Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS
Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.
Hocking LJ; Mellis DJ; McCabe PS; Helfrich MH; Rogers MJ
Biochem Biophys Res Commun; 2010 Nov; 402(3):543-8. PubMed ID: 20971078
[TBL] [Abstract][Full Text] [Related]
17. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination.
Wooten MW; Geetha T; Seibenhener ML; Babu JR; Diaz-Meco MT; Moscat J
J Biol Chem; 2005 Oct; 280(42):35625-9. PubMed ID: 16079148
[TBL] [Abstract][Full Text] [Related]
18. SQSTM-1/p62 potentiates HTLV-1 Tax-mediated NF-κB activation through its ubiquitin binding function.
Schwob A; Teruel E; Dubuisson L; Lormières F; Verlhac P; Abudu YP; Gauthier J; Naoumenko M; Cloarec-Ung FM; Faure M; Johansen T; Dutartre H; Mahieux R; Journo C
Sci Rep; 2019 Nov; 9(1):16014. PubMed ID: 31690813
[TBL] [Abstract][Full Text] [Related]
19. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
Yan XY; Zhang Y; Zhang JJ; Zhang LC; Liu YN; Wu Y; Xue YN; Lu SY; Su J; Sun LK
Cancer Sci; 2017 Jul; 108(7):1405-1413. PubMed ID: 28498503
[TBL] [Abstract][Full Text] [Related]
20. Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition.
Garner TP; Long J; Layfield R; Searle MS
Biochemistry; 2011 May; 50(21):4665-74. PubMed ID: 21517082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
